DrugInformations.org

UQ’s cutting edge technology has expanded with the acquisition of an Australian first animal scanner system, part of a new National Imaging Facility (NIF). Minister for Tourism, Regional Development and Industry Desley Boyle today opened the new facility at the UQ node, which will provide first-class imaging of animals, plants and materials for the Australian research community. The UQ node will be based at the Centre for Magnetic Resonance and house the $4.

More: continued here

No Comments »

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it is offering a new layout for the CyberKnife® Robotic Radiosurgery System treatment vault which will enable installation of the System into most existing conventional gantry LINAC vaults. With this new, smaller footprint, hospitals will be able to save hundreds of thousands of dollars or more on construction and shielding costs, and begin treating patients more quickly.

More: continued here

No Comments »

GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), announced a two-year cooperative research and development agreement with the National Cancer Institute (NCI) to accelerate the development of cutting-edge nanoparticle based imaging agents that have the potential to revolutionize the diagnosis and treatment of cancer and heart disease.

More: continued here

No Comments »

“My medical problems started in 1998, but I wasn’t diagnosed for five years” begins Carol Black of Cleveland, Ohio. “My doctor at the time wanted to do an MRI of my spine, because my symptoms mimicked those of multiple sclerosis. The MRI was denied by the insurance company, who claimed my symptoms were not severe enough to warrant the test. “Instead of MS, it turned out I had a severe spine problem called splondolythesis.

More: continued here

No Comments »

Cancer treatment specialists reported yesterday how new technologies are enabling them to provide faster, more accurate cancer treatments than was possible with earlier generations of radiotherapy technology.

More: continued here

No Comments »

Modern cancer care is critically dependent on imaging technologies, which are used to detect early tumors and guide their therapy or surgery. Molecular imaging technologies provide information about the functional or metabolic characteristics of malignancies, tumor stage and therapeutical response, and tumor recurrence; whereas conventional imaging technologies predominantly assess the tumor’s anatomical or morphologic features including its size, density, shape, etc.

More: continued here

No Comments »

The 2008 Lennart Nilsson Award for scientific photography will be presented to Swedish physician Anders Persson, MD, PhD, in recognition of his innovative techniques for capturing 3-D images inside the human body. These new techniques have proven particularly useful for post-mortem imaging, providing invaluable information for forensic investigation.

More: continued here

No Comments »

New MR techniques show that facet joint effusion (the collection of fluid in the spinal joints) and interspinal ligament edema (swelling of the interspinal ligaments) are major sources of lower back pain, according to a study performed at Baskent University Hospital in Ankara, Turkey and Alanya Research Center in Antalya, Turkey.

More: continued here

No Comments »

Doctors around the globe are turning more and more to the use of stereotactic body radiosurgery (SBRT) for the treatment of cancer and other conditions. Using the Novalis Tx platform from Varian Medical Systems (NYSE: VAR) and BrainLAB, doctors are performing image-guided radiosurgery to treat tumors of the brain, spine, lung, and liver, without a single incision in the patient.

More: continued here

No Comments »

Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Company’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s generic product is pharmaceutically equivalent to Cardiolite®1, a myocardial perfusion imaging agent used for detecting coronary artery disease.

More: continued here

No Comments »